This study aimed at comparing the effects of atorvastatin and vitamin E on erectile dysfunction in patients initially irresponsive to sildenafil, with investigation into the underlying possible mechanisms.
Sixty patients were randomly divided into three groups: the atorvastatin group received 80 mg daily, the vitamin E group received 400 IU daily and the control group received placebo capsules. Patients were examined both before and after 6 weeks of treatment for biochemical tests; Superoxide dismutase (SOD), glutathione peroxidase (GPO), C-reactive protein (CRP), interleukin-6 (IL-6), nitric oxide (NO) and endothelial nitric oxide synthase (eNOS) and for erectile function tests; International index of erectile function (IIEF-5) scores and Rigiscan. Both atorvastatin and vitamin E showed a statistically significant GPO increase (P< 0.05) and a statistically significant IL-6 decrease (P< 0.05). Only atorvastatin showed a statistically significant increase in NO (15.19%, P< 0.05), eNOS (20.58%, P< 0.01), IIEF-5 score (53.1%, P< 0.001) and Rigiscan rigidity parameters (P< 0.01), in addition to a statistically significant decrease in CRP (57.9%, P< 0.01). However, SOD showed a statistically significant increase only after vitamin E intake (23.1%, P< 0.05). Both atorvatstain and vitamin E had antioxidant and anti-inflammatory activities. Although activating eNOS by atorvastatin was the real difference, and expected to be the main mechanism for NO increase and for improving erectile dysfunction. Atorvastatin, but not vitamin E, is a promising drug for sildenafil nonresponders.
Written by:
El-Sisi AA, Hegazy SK, Salem KA, Abdelkawy KS. Are you the author?
Professor of Pharmacology and Toxicology, Pharmacology Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
Reference: Int J Impot Res. 2013 Jan 17. Epub ahead of print.
doi: 10.1038/ijir.2012.46
PubMed Abstract
PMID: 23324897
UroToday.com Erectile Dysfunction Section
